ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "308: An ASCO preview & another Duchenne trial failure"
Episode Synopsis
We preview some of the research that will be presented at The American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.
To about Merus' combination therapy, go here; For more on Johnson & Johnson's mixed data, click here; For more on Nippon Shinyaku's Duchenne drug trial failure, go here; To on Insmed's bronchiectasis treatment, click here; To sign up for STAT's ASCO newsletter, click here.
To about Merus' combination therapy, go here; For more on Johnson & Johnson's mixed data, click here; For more on Nippon Shinyaku's Duchenne drug trial failure, go here; To on Insmed's bronchiectasis treatment, click here; To sign up for STAT's ASCO newsletter, click here.
More episodes of the podcast The Readout Loud
382: Biotech's year in review
18/12/2025
In God we trust